For example, carbon nanoparticles or carbon dots with an average diameter of 3 nm were employed to degrade PD‐L1 using a ligand for the E3 CRBN.[82] In in vivo models, PD‐L1 degradation correlated with reduced tumor size and an enhanced immune response. The gene discussed is CD274; the disease is neoplasm.